News for Personalis, Inc. (PSNL)

Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX.

[url="]Personalis, Inc.[/url] (Nasdaq: PSNL), in collaboration with Professor Nick Turner, Dr. Isaac Garcia-Murillas and their colleagues at The Institute of C

Release Date: February 27, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Personalis I

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NPSNL.OQ - Personalis IncQ4 2024 Personalis Inc Earnings CallFeb 27, 2025 / 10:00PM GMT =======

Personalis, Inc. (NASDAQ:PSNL) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ETCompany ParticipantsCaroline Corner - Investor...

Personalis (PSNL) filed a prospectus related to the offer and resale of 14.04M shares of common stock for holders. This prospectus is not an offer to sell. Fili

Revenue: Achieved $84.6 million for the full year 2024, surpassing the annual estimate of $83.57 million and marking a 15% increase year-over-year.Cash Balance

Personalis (PSNL) delivered earnings and revenue surprises of 8% and 0.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the fourth quarter and full year en

Personalis Inc (PSNL) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue is $15.74 million, and the earnings are

**media[550320]**

Personalis (PSNL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the TD Cowen'

Overview of the Recent Transaction On December 31, 2024, Catherine Wood (Trades, Portfolio), the founder of ARK, executed a strategic reduction in holdings of P

U.S. stocks were mostly lower, with the Dow Jones falling around 100 points on Friday. Shares of The Goodyear Tire & Rubber Company GT rose sharply during Frid...

Personalis shows promise in cancer detection but is years away from profitability. Read why PSNL stock is rated a hold with potential if margins improve.

Personalis (PSNL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

[url=

New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer